COMPUGEN LTD

Listed Company
CGENCIK 0001119774NasdaqAcceleratedBiological Products, (No Diagnostic Substances)L3ILFY ends Dec 31
Period
FY 2025
Revenue
$72.76M
Net Income
$35.34M
Total Assets
$156.57M
Equity
$102.73M
Shares Out
94.55M
Op. Cash Flow
$31.63M
CGEN$2.37+49.53% · past yearDBEQ Basic
Daily closing prices

Business

Compugen Ltd. is a clinical-stage therapeutic discovery and development company utilizing its Unigen AI/ML-powered computational platform to identify novel drug targets and develop therapeutics in cancer immunotherapy. The company's pipeline includes four clinical-stage immuno-oncology programs: COM701 (anti-PVRIG antibody), COM902 (anti-TIGIT antibody), rilvegostomig (PD-1/TIGIT bispecific, licensed to AstraZeneca), and GS-0321 (anti-IL-18BP antibody, licensed to Gilead). Compugen operates through collaborations and licensing arrangements with pharmaceutical partners including AstraZeneca and Gilead, generating revenue through upfront payments, milestones, and royalties on product sales.

Summary from 20-F filed 2026-03-02

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue$72.76M
Net income$35.34M
Total assets$156.57M
Total liabilities—
Stockholders' equity$102.73M
Operating cash flow$31.63M

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is COMPUGEN LTD's CIK number?

COMPUGEN LTD's SEC CIK number is 0001119774 (1119774). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find COMPUGEN LTD's SEC filings?

All of COMPUGEN LTD's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

Look up any company's CIK number →